This site became the new on June 19th. Learn more.
Show more Menu IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more... Menu IMPORTANT: Talk with a trusted healthcare professional before volunteering for a study. Read more... Menu
Give us feedback

Early Endoscopic Indicators for OACs After Lung Transplantation: Development of a Novel Mucosal Healing Score (OAC)

This study has been completed.
Information provided by (Responsible Party):
Thomas Fuehner, Hannover Medical School Identifier:
First received: July 14, 2009
Last updated: June 5, 2013
Last verified: June 2013
Airway complications are a significant cause of morbidity after lung transplantation (LTx). Bronchoscopic evaluation may help to identify risk factors for requiring interventions later.

Airway Complication Which Require Any Intervention

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Prospective
Official Title: Early Indicators for Obstructive Airway Complications After Lung

Resource links provided by NLM:

Further study details as provided by Thomas Fuehner, Hannover Medical School:

Primary Outcome Measures:
  • Primary endpoint of this study was any obstructive airway complication (AC) which required desobliterative intervention. [ Time Frame: 1 year ]

Secondary Outcome Measures:
  • secondary endpoint included anastomosis-related death. [ Time Frame: 1 year ]

Enrollment: 180
Study Start Date: January 2007
Study Completion Date: August 2009
Primary Completion Date: June 2009 (Final data collection date for primary outcome measure)
patients with OAC, Score finding
patients without OAC, Score finding

Detailed Description:
The investigators evaluated lung transplant recipients prospectively. Adult patients surviving 90 day after LTx will be included. The investigators propose a classification of airway healing based on the endoscopic bronchial appearances at days 7, 14, 21, 90, 180 and 365 after LTx. A score system including mucosal healing, full tissue necrosis (=dehiscence), lose sutures, fibrin plugs, polyps and malacia will be developed (max. score 8 points/date). Endoscopic findings will be correlated with the development of obstructive airway complications (OAC, requiring >1 intervention). Afterwards the new score system will be applied prospectively in the patients.

Ages Eligible for Study:   18 Years to 80 Years   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Probability Sample
Study Population
LTx 01.2007-05.2009

Inclusion Criteria:

  • 3 month survivor after LTx
  • no OAC

Exclusion Criteria:

  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT00940147

Hannover Medical School
Hannover, Germany, 30625
Sponsors and Collaborators
Thomas Fuehner
  More Information

Additional Information:
Responsible Party: Thomas Fuehner, Principal Investigator, Hannover Medical School Identifier: NCT00940147     History of Changes
Other Study ID Numbers: 2008_01
Study First Received: July 14, 2009
Last Updated: June 5, 2013 processed this record on September 21, 2017